Grantham, Mayo, Van Otterloo & Co (GMO)’s Aemetis AMTX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMTX
Grantham, Mayo, Van Otterloo & Co (GMO)'s AMTX Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Aemetis (AMTX) stake by 1.4% in Q2 2026, buying an estimated $35K and bringing the position to 1,064,317 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #466.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AMTX in Q2 2021 and has held it in 21 quarters since. The position peaked at $35.1M in Q3 2021. 88 funds tracked by Wall St. Rank hold AMTX as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 1,064,317 shares of Aemetis worth $1.75M as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 14,300 Aemetis shares in Q2 2026, an estimated $35K.
- Aemetis made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #466 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Aemetis in Q2 2021 and has held it in 21 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Aemetis position peaked at $35.1M in Q3 2021.
- 88 funds tracked by Wall St. Rank held Aemetis as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.